Global Trade & Foreign Policy Insights
Topics
Contributors
Sort by:
1 result
December 23, 2019
|2 min read
According to news articles published in early December, Veritas Genetics, a Massachusetts-based company that hoped to lower the cost of whole-genome sequencing, is suspending its U.S. operations because of a lack of investment. Articles theorize that the decreased funding was driven mainly by new CFIUS regulations and heightened CFIUS scrutiny.
About This Blog
Global Trade & Foreign Policy Insights addresses rapidly evolving U.S. foreign policy and its impact on cross-border trade. We address the impact on financial services, supply chains, and manufacturing. We also cover the international community’s response to U.S. foreign policy.
Contributors
Partner
Of Counsel
Of Counsel
Associate
Associate
Related Capabilities
Related Insights & News
Press Release
Winston & Strawn Launches New Global Privacy & Data Security Practice
August 24, 2020
Blog
Veritas, a U.S. Genetic Sequencing Company, Suspends U.S. Operations Due to Decreased Funding; CFIUS Thought to be Leading Cause
December 23, 2019